Longevity Research
Autophagy & Mitochondrial Health Research Protocol
Educational protocol for compounds researched in autophagy induction, mitophagy, and mitochondrial biogenesis in aging biology
• This protocol is provided for educational and informational purposes only. It does not constitute medical advice, a diagnosis, a treatment plan, or a prescription.
• All dose ranges, frequencies, durations, and compound selections must be determined by a licensed healthcare professional based on your individual medical history, lab results, and clinical assessment.
• Lab monitoring may be required depending on the compound(s), individual health status, and duration of use. Discuss appropriate monitoring protocols with your clinician.
• Do not use any peptide compound if you are pregnant, breastfeeding, a minor, or have uncontrolled medical conditions without explicit direction from your physician.
Overview
This educational protocol covers research discussion points for mitochondrial-derived peptides and compounds studied in the context of autophagy regulation, mitophagy, and mitochondrial biogenesis. These compounds represent a frontier area of aging biology research with limited human clinical data. Clinician consultation is essential.
Mechanism Summary
MOTS-c is encoded in the mitochondrial 12S rRNA and acts as a metabolic regulator by activating AMPK and inhibiting the folate cycle, studied for its role in insulin sensitivity and longevity pathways. Humanin is a mitochondrial open reading frame peptide studied for cytoprotective effects against apoptotic stimuli, with potential roles in neurodegeneration and metabolic protection. SS-31 (Elamipretide) is a synthetic aromatic-cationic tetrapeptide that selectively targets cardiolipin in the inner mitochondrial membrane, stabilising its interaction with cytochrome c and studied for improving mitochondrial ATP production in models of cardiac and age-related cellular dysfunction.
Intended Goal
Prepare for a clinician consultation on peptide compounds studied in autophagy, mitophagy, and mitochondrial function research contexts
MOTS-c
Mitochondrial-derived peptide / metabolic / longevity
Mitochondrial open reading frame peptide studied for metabolic regulation and AMPK activation. Catalog reference.
Humanin
Mitochondrial-derived peptide / cytoprotective / neuroprotective
Mitochondrial-derived peptide studied for cytoprotective and anti-apoptotic properties in aging research. Catalog reference.
SS-31 (Elamipretide)
Mitochondrial membrane cardioprotection / ATP production
Synthetic tetrapeptide targeting cardiolipin in the inner mitochondrial membrane. Studied in heart failure and aging research contexts. Catalog reference.
Research reference values only. Confirm all parameters with current literature and your clinician.
Who may be a candidate
- ✓Adults working with longevity or functional medicine clinicians exploring mitochondrial health research
- ✓Individuals with clinician-confirmed mitochondrial dysfunction under specialist care
- ✓Those interested in aging biology research seeking an educational framework for clinical discussion
Exclusions
- ✕Not appropriate for healthy individuals seeking anti-aging compounds without medical supervision
- ✕Not appropriate without active clinician oversight
- ✕Research compounds in this category have very limited human safety data
Do I have evidence of mitochondrial dysfunction that warrants considering these compounds?
How do you evaluate MOTS-c or Humanin in a clinical longevity context?
Is SS-31 relevant to my cardiovascular or metabolic health picture?
How would you differentiate placebo from actual mitochondrial benefit?
What lifestyle interventions would you prioritise alongside any peptide discussion?
Print or copy these questions using the "Copy Summary" button to bring to your appointment.
Legal & Compliance Notice
MOTS-c, Humanin, and SS-31 are research compounds not approved for therapeutic use in most jurisdictions. Verify current regulatory status with a licensed clinician.
The legal and regulatory status of research compounds varies by country and jurisdiction. It is the user's responsibility to understand applicable local laws before engaging with any compound.
This application does not provide personalized dosing recommendations. Users who require medical guidance should consult a qualified clinician.
Last reviewed: 2025-03-01 · Status: reviewed
Discuss with Your Clinician
Use this protocol as a research starting point. A qualified healthcare professional can review your health history, order appropriate labs, and help you determine what approach — if any — makes sense for your specific situation.